跳到內容

輸血替代療法的效益

腫瘤科

Should intravenous iron be the standard of care in oncology? (開啟新視窗)

Auerbach M.

出處‎: J Clin Oncol 2008;26(10):1579-81.

檢索‎: PubMed 18375888

DOI碼‎: 10.1200/JCO.2007.15.4609

https://www.ncbi.nlm.nih.gov/pubmed/18375888 (開啟新視窗)

Cost of outpatient blood transfusion in cancer patients. (開啟新視窗)

Crémieux PY, Barrett B, Anderson K, Slavin MB.

出處‎: J Clin Oncol 2000;18(14):2755-61.

檢索‎: PubMed 10894876

DOI碼‎: 10.1200/JCO.2000.18.14.2755

https://www.ncbi.nlm.nih.gov/pubmed/10894876 (開啟新視窗)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (開啟新視窗)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

出處‎: Transfusion 2015;55(12):2807-15.

檢索‎: PubMed 26264557

DOI碼‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (開啟新視窗)